MLH1 and colorectal carcinoma: BRAF mutations occur in about 10 to 18% of CRC overall and in 30 to 45% of MSI CRC [2,3], more frequently in tumours harbouring MLH1 promoter hypermethylation [3] and with a CpG island methylation phenotype (CIMP) [4].